NeoCov coronavirus found in bats may pose threat to humans in the future, scientists caution.

Coronavirus: A quick backgrounder

• Coronaviruses are a large family of viruses that are known to infect animals and humans.
• They are largely categorized into four genera — alpha, beta, gamma, and delta.
• Broadly speaking, alpha and beta coronaviruses commonly infect mammals such as bats and humans, while Gamma and Delta mainly infect birds.

Infecting humans: Through ‘Zoonotic Spillover’

• While animals, including bats, are generally considered as the reservoirs of coronaviruses, rarely spillover events could occur.
• It is possible for viruses that infect animals to jump to humans, a process which is known as zoonotic spillover.
• Many major infectious diseases, including COVID-19, is widely thought to be a result of spillover.

COVID-19 Pandemic

• SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic, belongs to the genus of beta coronavirus.
• It is in fact the 7th type of coronavirus known to infect and cause severe disease in humans.

How does it affect humans?

• How a coronavirus latches onto special receptors on host cells depends on a key part of the virus known as its receptor-binding domain.
• The differences in the receptor-binding domain of coronaviruses are therefore what determine the type of host receptor the virus will use and thus the host that it will be able to infect.
• There are currently 4 well-characterized receptors for coronaviruses, including ACE2, which is used by SARS-CoV and SARS-CoV-2, and DPP4 used by MERS-CoV.

What is NeoCoV?

• NeoCoV is a bat coronavirus that was first identified in 2011.
• It was identified in a species of bats known as Neoromicia, which is where the name NeoCoV was derived from.
• Commonly known as aloe bats, this species is distributed in the Afro-Malagasy region.
• NeoCoV shares an 85% similarity to MERS-CoV in the genome sequence, making it the closest known relative of MERS-CoV.

Does NeoCoV infect humans and cause high mortality?

• It is important to note that inherently, NeoCoV cannot interact with human receptors, implying that in its current form the virus cannot infect humans.
• NeoCoV does not infect humans yet and has thus not caused any deaths.

What does the preprint say and why is it important?

• The study reports that despite their similarity, MERS-CoV and NeoCoV use different receptors to infect cells.
• The bat coronavirus NeoCoV was found to use bat ACE2 receptors for efficiently entering cells.
• The interaction between NeoCoV and bat ACE2 receptors is different from what is seen in other coronaviruses that utilize ACE2.
• However, specific mutations artificially created in the receptor-binding domain of NeoCoV can enhance its efficiency to interact with human ACE2 receptors.
• These mutations have not yet been seen in NeoCov isolates from natural settings.

Conclusion

• SARS-CoV-2 is not the first coronavirus to infect humans and cause large disease outbreaks, nor is it likely to be the last.
• The study highlights that through further adaptation, coronaviruses like NeoCoV or other related viruses could potentially gain the ability to infect humans.

Way forward

• To prevent future outbreaks, it will thus be important to monitor this family of viruses for potential zoonosis while continuing research efforts on understanding the complex receptor usage of different coronaviruses.
• Genomic surveillance of human and animal viruses is, therefore, the key to understanding the spectrum of viruses, and possibly provides early warning to potential spillover events.

Try this question from CSP 2021:

Q. The term ACE2′ is talked about in the context of:

(a) genes introduced in the genetically modified plants

(b) development of India’s own satellite navigation system

(c) radio collars for wildlife tracking

(d) spread of viral diseases

 

Post your answers here.

3

Please leave a feedback on thisx

UPSC 2022 countdown has begun! Get your personal guidance plan now! (Click here)

Get an IAS/IPS ranker as your 1: 1 personal mentor for UPSC 2024

Attend Now